arXiv subjects

Mark J. van der Laan

Publications and source records attributed to Mark J. van der Laan.

At least 37 records · Page 2Linked to original sources

arXiv2025

concrete: Targeted Estimation of Survival and Competing Risks in Continuous Time

This article introduces the R package concrete, which implements a recently developed targeted maximum likelihood estimator (TMLE) for the cause-specific absolute risks of time-to-event outcomes measured in continuous time. Cross-validated Super Learner machine learning ensembles are used to estimate propensity scores and conditional cause-specific hazards, which are then targeted to produce robust and efficient plug-in estimates of the effects of static or dynamic interventions on a binary treatment given at baseline quantified as risk differences or risk ratios. Influence curve-based asymptotic inference is provided for TMLE estimates and simultaneous confidence bands can be computed for target estimands spanning multiple multiple times or events. In this paper we review the one-step continuous-time TMLE methodology as it is situated in an overarching causal inference workflow, describe its implementation, and demonstrate the use of the package on the PBC dataset.

stat.CO↗

arXiv2024

[Invited Discussion] Randomization Tests to Address Disruptions in Clinical Trials: A Report from the NISS Ingram Olkin Forum Series on Unplanned Clinical Trial Disruptions

Disruptions in clinical trials may be due to external events like pandemics, warfare, and natural disasters. Resulting complications may lead to unforeseen intercurrent events (events that occur after treatment initiation and affect the interpretation of the clinical question of interest or the existence of the measurements associated with it). In Uschner et al. (2023), several example clinical trial disruptions are described: treatment effect drift, population shift, change of care, change of data collection, and change of availability of study medication. A complex randomized controlled trial (RCT) setting with (planned or unplanned) intercurrent events is then described, and randomization tests are presented as a means for non-parametric inference that is robust to violations of assumption typically made in clinical trials. While estimation methods like Targeted Learning (TL) are valid in such settings, we do not see where the authors make the case that one should be going for a randomization test in such disrupted RCTs. In this discussion, we comment on the appropriateness of TL and the accompanying TL Roadmap in the context of disrupted clinical trials. We highlight a few key articles related to the broad applicability of TL for RCTs and real-world data (RWD) analyses with intercurrent events. We begin by introducing TL and motivating its utility in Section 2, and then in Section 3 we provide a brief overview of the TL Roadmap. In Section 4 we recite the example clinical trial disruptions presented in Uschner et al. (2023), discussing considerations and solutions based on the principles of TL. We request in an authors' rejoinder a clear theoretical demonstration with specific examples in this setting that a randomization test is the only valid inferential method relative to one based on following the TL Roadmap.

stat.AP↗

arXiv2024

Semiparametric Discovery and Estimation of Interaction in Mixed Exposures using Stochastic Interventions

This study introduces a nonparametric definition of interaction and provides an approach to both interaction discovery and efficient estimation of this parameter. Using stochastic shift interventions and ensemble machine learning, our approach identifies and quantifies interaction effects through a model-independent target parameter, estimated via targeted maximum likelihood and cross-validation. This method contrasts the expected outcomes of joint interventions with those of individual interventions. Validation through simulation and application to the National Institute of Environmental Health Sciences Mixtures Workshop data demonstrate the efficacy of our method in detecting true interaction directions and its consistency in identifying significant impacts of furan exposure on leukocyte telomere length. Our method, called InterXshift, advances the ability to analyze multi-exposure interactions within high-dimensional data, offering significant methodological improvements to understand complex exposure dynamics in health research. We provide peer-reviewed open-source software that employs or proposed methodology in the InterXshift R package.

stat.ME↗

arXiv2024

Estimating conditional hazard functions and densities with the highly-adaptive lasso

We consider estimation of conditional hazard functions and densities over the class of multivariate càdlàg functions with uniformly bounded sectional variation norm when data are either fully observed or subject to right-censoring. We demonstrate that the empirical risk minimizer is either not well-defined or not consistent for estimation of conditional hazard functions and densities. Under a smoothness assumption about the data-generating distribution, a highly-adaptive lasso estimator based on a particular data-adaptive sieve achieves the same convergence rate as has been shown to hold for the empirical risk minimizer in settings where the latter is well-defined. We use this result to study a highly-adaptive lasso estimator of a conditional hazard function based on right-censored data. We also propose a new conditional density estimator and derive its convergence rate. Finally, we show that the result is of interest also for settings where the empirical risk minimizer is well-defined, because the highly-adaptive lasso depends on a much smaller number of basis function than the empirical risk minimizer.

math.ST↗

arXiv2023

Nonparametric estimation of a covariate-adjusted counterfactual treatment regimen response curve

Flexible estimation of the mean outcome under a treatment regimen (i.e., value function) is the key step toward personalized medicine. We define our target parameter as a conditional value function given a set of baseline covariates which we refer to as a stratum based value function. We focus on semiparametric class of decision rules and propose a sieve based nonparametric covariate adjusted regimen-response curve estimator within that class. Our work contributes in several ways. First, we propose an inverse probability weighted nonparametrically efficient estimator of the smoothed regimen-response curve function. We show that asymptotic linearity is achieved when the nuisance functions are undersmoothed sufficiently. Asymptotic and finite sample criteria for undersmoothing are proposed. Second, using Gaussian process theory, we propose simultaneous confidence intervals for the smoothed regimen-response curve function. Third, we provide consistency and convergence rate for the optimizer of the regimen-response curve estimator; this enables us to estimate an optimal semiparametric rule. The latter is important as the optimizer corresponds with the optimal dynamic treatment regimen. Some finite-sample properties are explored with simulations.

math.ST↗

arXiv2023

An Approach to Nonparametric Inference on the Causal Dose Response Function

The causal dose response curve is commonly selected as the statistical parameter of interest in studies where the goal is to understand the effect of a continuous exposure on an outcome.Most of the available methodology for statistical inference on the dose-response function in the continuous exposure setting requires strong parametric assumptions on the probability distribution. Such parametric assumptions are typically untenable in practice and lead to invalid inference. It is often preferable to instead use nonparametric methods for inference, which only make mild assumptions about the data-generating mechanism. We propose a nonparametric test of the null hypothesis that the dose-response function is equal to a constant function. We argue that when the null hypothesis holds, the dose-response function has zero variance. Thus, one can test the null hypothesis by assessing whether there is sufficient evidence to claim that the variance is positive. We construct a novel estimator for the variance of the dose-response function, for which we can fully characterize the null limiting distribution and thus perform well-calibrated tests of the null hypothesis. We also present an approach for constructing simultaneous confidence bands for the dose-response function by inverting our proposed hypothesis test. We assess the validity of our proposal in a simulation study. In a data example, we study, in a population of patients who have initiated treatment for HIV, how the distance required to travel to an HIV clinic affects retention in care.

stat.ME↗

arXiv2023

Defining and Estimating Effects in Cluster Randomized Trials: A Methods Comparison

Across research disciplines, cluster randomized trials (CRTs) are commonly implemented to evaluate interventions delivered to groups of participants, such as communities and clinics. Despite advances in the design and analysis of CRTs, several challenges remain. First, there are many possible ways to specify the causal effect of interest (e.g., at the individual-level or at the cluster-level). Second, the theoretical and practical performance of common methods for CRT analysis remain poorly understood. Here, we present a general framework to formally define an array of causal effects in terms of summary measures of counterfactual outcomes. Next, we provide a comprehensive overview of CRT estimators, including the t-test, generalized estimating equations (GEE), augmented-GEE, and targeted maximum likelihood estimation (TMLE). Using finite sample simulations, we illustrate the practical performance of these estimators for different causal effects and when, as commonly occurs, there are limited numbers of clusters of different sizes. Finally, our application to data from the Preterm Birth Initiative (PTBi) study demonstrates the real-world impact of varying cluster sizes and targeting effects at the cluster-level or at the individual-level. Specifically, the relative effect of the PTBI intervention was 0.81 at the cluster-level, corresponding to a 19% reduction in outcome incidence, and was 0.66 at the individual-level, corresponding to a 34% reduction in outcome risk. Given its flexibility to estimate a variety of user-specified effects and ability to adaptively adjust for covariates for precision gains while maintaining Type-I error control, we conclude TMLE is a promising tool for CRT analysis.

stat.ME↗

arXiv2023

Practical considerations for specifying a super learner

Common tasks encountered in epidemiology, including disease incidence estimation and causal inference, rely on predictive modeling. Constructing a predictive model can be thought of as learning a prediction function, i.e., a function that takes as input covariate data and outputs a predicted value. Many strategies for learning these functions from data are available, from parametric regressions to machine learning algorithms. It can be challenging to choose an approach, as it is impossible to know in advance which one is the most suitable for a particular dataset and prediction task at hand. The super learner (SL) is an algorithm that alleviates concerns over selecting the one "right" strategy while providing the freedom to consider many of them, such as those recommended by collaborators, used in related research, or specified by subject-matter experts. It is an entirely pre-specified and data-adaptive strategy for predictive modeling. To ensure the SL is well-specified for learning the prediction function, the analyst does need to make a few important choices. In this Education Corner article, we provide step-by-step guidelines for making these choices, walking the reader through each of them and providing intuition along the way. In doing so, we aim to empower the analyst to tailor the SL specification to their prediction task, thereby ensuring their SL performs as well as possible. A flowchart provides a concise, easy-to-follow summary of key suggestions and heuristics, based on our accumulated experience, and guided by theory.

stat.ME↗

arXiv2023

Multi-task Highly Adaptive Lasso

We propose a novel, fully nonparametric approach for the multi-task learning, the Multi-task Highly Adaptive Lasso (MT-HAL). MT-HAL simultaneously learns features, samples and task associations important for the common model, while imposing a shared sparse structure among similar tasks. Given multiple tasks, our approach automatically finds a sparse sharing structure. The proposed MTL algorithm attains a powerful dimension-free convergence rate of $o_p(n^{-1/4})$ or better. We show that MT-HAL outperforms sparsity-based MTL competitors across a wide range of simulation studies, including settings with nonlinear and linear relationships, varying levels of sparsity and task correlations, and different numbers of covariates and sample size.

stat.ML↗

arXiv2022

Adaptive Sequential Surveillance with Network and Temporal Dependence

Strategic test allocation plays a major role in the control of both emerging and existing pandemics (e.g., COVID-19, HIV). Widespread testing supports effective epidemic control by (1) reducing transmission via identifying cases, and (2) tracking outbreak dynamics to inform targeted interventions. However, infectious disease surveillance presents unique statistical challenges. For instance, the true outcome of interest - one's positive infectious status, is often a latent variable. In addition, presence of both network and temporal dependence reduces the data to a single observation. As testing entire populations regularly is neither efficient nor feasible, standard approaches to testing recommend simple rule-based testing strategies (e.g., symptom based, contact tracing), without taking into account individual risk. In this work, we study an adaptive sequential design involving n individuals over a period of τ time-steps, which allows for unspecified dependence among individuals and across time. Our causal target parameter is the mean latent outcome we would have obtained after one time-step, if, starting at time t given the observed past, we had carried out a stochastic intervention that maximizes the outcome under a resource constraint. We propose an Online Super Learner for adaptive sequential surveillance that learns the optimal choice of tests strategies over time while adapting to the current state of the outbreak. Relying on a series of working models, the proposed method learns across samples, through time, or both: based on the underlying (unknown) structure in the data. We present an identification result for the latent outcome in terms of the observed data, and demonstrate the superior performance of the proposed strategy in a simulation modeling a residential university environment during the COVID-19 pandemic.

stat.ME↗

arXiv2022

Revisiting the propensity score's central role: Towards bridging balance and efficiency in the era of causal machine learning

About forty years ago, in a now--seminal contribution, Rosenbaum & Rubin (1983) introduced a critical characterization of the propensity score as a central quantity for drawing causal inferences in observational study settings. In the decades since, much progress has been made across several research fronts in causal inference, notably including the re-weighting and matching paradigms. Focusing on the former and specifically on its intersection with machine learning and semiparametric efficiency theory, we re-examine the role of the propensity score in modern methodological developments. As Rosenbaum & Rubin (1983)'s contribution spurred a focus on the balancing property of the propensity score, we re-examine the degree to which and how this property plays a role in the development of asymptotically efficient estimators of causal effects; moreover, we discuss a connection between the balancing property and efficient estimation in the form of score equations and propose a score test for evaluating whether an estimator achieves balance.

stat.ME↗

arXiv2022

Efficient estimation of modified treatment policy effects based on the generalized propensity score

Continuous treatments have posed a significant challenge for causal inference, both in the formulation and identification of scientifically meaningful effects and in their robust estimation. Traditionally, focus has been placed on techniques applicable to binary or categorical treatments with few levels, allowing for the application of propensity score-based methodology with relative ease. Efforts to accommodate continuous treatments introduced the generalized propensity score, yet estimators of this nuisance parameter commonly utilize parametric regression strategies that sharply limit the robustness and efficiency of inverse probability weighted estimators of causal effect parameters. We formulate and investigate a novel, flexible estimator of the generalized propensity score based on a nonparametric function estimator that provably converges at a suitably fast rate to the target functional so as to facilitate statistical inference. With this estimator, we demonstrate the construction of nonparametric inverse probability weighted estimators of a class of causal effect estimands tailored to continuous treatments. To ensure the asymptotic efficiency of our proposed estimators, we outline several non-restrictive selection procedures for utilizing a sieve estimation framework to undersmooth estimators of the generalized propensity score. We provide the first characterization of such inverse probability weighted estimators achieving the nonparametric efficiency bound in a setting with continuous treatments, demonstrating this in numerical experiments. We further evaluate the higher-order efficiency of our proposed estimators by deriving and numerically examining the second-order remainder of the corresponding efficient influence function in the nonparametric model. Open source software implementing our proposed estimation techniques, the haldensify R package, is briefly discussed.

stat.ME↗

arXiv2022

Targeted learning: Towards a future informed by real-world evidence

The 21st Century Cures Act of 2016 includes a provision for the U.S. Food and Drug Administration (FDA) to evaluate the potential use of real-world evidence (RWE) to support new indications for use for previously approved drugs, and to satisfy post-approval study requirements. Extracting reliable evidence from real-world data (RWD) is often complicated by a lack of treatment randomization, potential intercurrent events, and informative loss to follow up. Targeted Learning (TL) is a sub-field of statistics that provides a rigorous framework to help address these challenges. The TL Roadmap offers a step-by-step guide to generating valid evidence and assessing its reliability. Following these steps produces an extensive amount of information for assessing whether the study provides reliable scientific evidence in support regulatory decision making. This paper presents two case studies that illustrate the utility of following the roadmap. We use targeted minimum loss-based estimation combined with super learning to estimate causal effects. We also compared these findings with those obtained from an unadjusted analysis, propensity score matching, and inverse probability weighting. Non-parametric sensitivity analyses illuminate how departures from (untestable) causal assumptions would affect point estimates and confidence interval bounds that would impact the substantive conclusion drawn from the study. TL's thorough approach to learning from data provides transparency, allowing trust in RWE to be earned whenever it is warranted.

stat.AP↗

arXiv2022

Causal inference for social network data

We describe semiparametric estimation and inference for causal effects using observational data from a single social network. Our asymptotic results are the first to allow for dependence of each observation on a growing number of other units as sample size increases. In addition, while previous methods have implicitly permitted only one of two possible sources of dependence among social network observations, we allow for both dependence due to transmission of information across network ties and for dependence due to latent similarities among nodes sharing ties. We propose new causal effects that are specifically of interest in social network settings, such as interventions on network ties and network structure. We use our methods to reanalyze an influential and controversial study that estimated causal peer effects of obesity using social network data from the Framingham Heart Study; after accounting for network structure we find no evidence for causal peer effects.

stat.ME↗

arXiv2022

A Flexible Approach for Predictive Biomarker Discovery

An endeavor central to precision medicine is predictive biomarker discovery; they define patient subpopulations which stand to benefit most, or least, from a given treatment. The identification of these biomarkers is often the byproduct of the related but fundamentally different task of treatment rule estimation. Using treatment rule estimation methods to identify predictive biomarkers in clinical trials where the number of covariates exceeds the number of participants often results in high false discovery rates. The higher than expected number of false positives translates to wasted resources when conducting follow-up experiments for drug target identification and diagnostic assay development. Patient outcomes are in turn negatively affected. We propose a variable importance parameter for directly assessing the importance of potentially predictive biomarkers, and develop a flexible nonparametric inference procedure for this estimand. We prove that our estimator is double-robust and asymptotically linear under loose conditions on the data-generating process, permitting valid inference about the importance metric. The statistical guarantees of the method are verified in a thorough simulation study representative of randomized control trials with moderate and high-dimensional covariate vectors. Our procedure is then used to discover predictive biomarkers from among the tumor gene expression data of metastatic renal cell carcinoma patients enrolled in recently completed clinical trials. We find that our approach more readily discerns predictive from non-predictive biomarkers than procedures whose primary purpose is treatment rule estimation. An open-source software implementation of the methodology, the uniCATE R package, is briefly introduced.

stat.ME↗

arXiv2022

Cross-Validated Loss-Based Covariance Matrix Estimator Selection in High Dimensions

The covariance matrix plays a fundamental role in many modern exploratory and inferential statistical procedures, including dimensionality reduction, hypothesis testing, and regression. In low-dimensional regimes, where the number of observations far exceeds the number of variables, the optimality of the sample covariance matrix as an estimator of this parameter is well-established. High-dimensional regimes do not admit such a convenience, however. As such, a variety of estimators have been derived to overcome the shortcomings of the sample covariance matrix in these settings. Yet, the question of selecting an optimal estimator from among the plethora available remains largely unaddressed. Using the framework of cross-validated loss-based estimation, we develop the theoretical underpinnings of just such an estimator selection procedure. In particular, we propose a general class of loss functions for covariance matrix estimation and establish finite-sample risk bounds and conditions for the asymptotic optimality of the cross-validated estimator selector with respect to these loss functions. We evaluate our proposed approach via a comprehensive set of simulation experiments and demonstrate its practical benefits by application in the exploratory analysis of two single-cell transcriptome sequencing datasets. A free and open-source software implementation of the proposed methodology, the cvCovEst R package, is briefly introduced.

stat.ME↗

arXiv2022

A generalization of moderated statistics to data adaptive semiparametric estimation in high-dimensional biology

The widespread availability of high-dimensional biological data has made the simultaneous screening of many biological characteristics a central problem in computational biology and allied sciences. While the dimensionality of such datasets continues to grow, so too does the complexity of biomarker identification from exposure patterns in health studies measuring baseline confounders; moreover, doing so while avoiding model misspecification remains an issue only partially addressed. Efficient estimators capable of incorporating flexible, data adaptive regression techniques in estimating relevant components of the data-generating distribution provide an avenue for avoiding model misspecification; however, in the context of high-dimensional problems that require the simultaneous estimation of numerous parameters, standard variance estimators have proven unstable, resulting in unreliable Type-I error control even under standard multiple testing corrections. We present a general approach for applying empirical Bayes shrinkage to variance estimators of a family of efficient, asymptotically linear estimators of population intervention causal effects. Our generalization of shrinkage-based variance estimators increases inferential stability in high-dimensional settings, facilitating the application of these estimators for deriving nonparametric variable importance measures in high-dimensional biological datasets with modest sample sizes. The result is a data adaptive approach for robustly uncovering stable causal associations in high-dimensional data in studies with limited samples. Our generalized variance estimator is evaluated against alternative variance estimators in numerical experiments. Identification of biomarkers with the proposed methodology is demonstrated in an analysis of high-dimensional DNA methylation data from an observational study on the epigenetic effects of tobacco smoking.

stat.ME↗

arXiv2022

Nonparametric causal mediation analysis for stochastic interventional (in)direct effects

Causal mediation analysis has historically been limited in two important ways: (i) a focus has traditionally been placed on binary treatments and static interventions, and (ii) direct and indirect effect decompositions have been pursued that are only identifiable in the absence of intermediate confounders affected by treatment. We present a theoretical study of an (in)direct effect decomposition of the population intervention effect, defined by stochastic interventions jointly applied to the treatment and mediators. In contrast to existing proposals, our causal effects can be evaluated regardless of whether a treatment is categorical or continuous and remain well-defined even in the presence of intermediate confounders affected by treatment. Our (in)direct effects are identifiable without a restrictive assumption on cross-world counterfactual independencies, allowing for substantive conclusions drawn from them to be validated in randomized controlled trials. Beyond the novel effects introduced, we provide a careful study of nonparametric efficiency theory relevant for the construction of flexible, multiply robust estimators of our (in)direct effects, while avoiding undue restrictions induced by assuming parametric models of nuisance parameter functionals. To complement our nonparametric estimation strategy, we introduce inferential techniques for constructing confidence intervals and hypothesis tests, and discuss open source software implementing the proposed methodology.

stat.ME↗